2nd Quarter - Amendment
ZIMMER BIOMET, INC. for ZIMMER BIOMET, INC.
Firm
Client
Income
—
Expenses
$120,000
Expense method
A: Lobbying Disclosure Act definitions
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 20, 2016 | $110,000 | Replaced |
| 2nd Quarter - Amendment (this page) | Jul 20, 2016 | $120,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Energy and Commerce Committee's 21st Century Cures; Medicare payment (CCJR and proposed Medicare Inpatient Payment and Physician Payment Rules); FDA inspections; FY17 Ag Appropriations; MDUFA Reauthorization; FDA re-processing regulations
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER A CERONE | — |
| WHITNEY TULL | — |
Taxation/Internal Revenue Code TAX
Corporate Tax Reform, MDET Repeal
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER A CERONE | — |
| WHITNEY TULL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.